10.1007/s12161-013-9621-9 [DOI] [Google Scholar] Barros L., Correia D
Arch Dermatol 145(4):379382 Kodera R, Shikata K, Kataoka HU, Takatsuka T, Miyamoto S, Sasaki M, Kajitani N, Nishishita S, Sarai K, Hirota D, Sato C, Ogawa D, Makino H (2011) Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
Aquaculture 444, 112.CrossRefGoogle ScholarPubMed Oreochromis niloticus )
Interestingly, the response differed across BDNF exons: exon I increased rapidly, especially in the CA1 region, while exons III and IV showed minimal changes
Market for GLP-1s is still nascent in India but is growing rapidly evident by rapid growth in sales for Wegovy and Mounjaro